Clinical Trials

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05883644 2026-04-30

SIERRA

111 enrolled

Liver Neoplasms

NCT05520099 2026-04-29

ELEPHAS-02

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

416 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT02954094 2026-04-17

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

10,000 enrolled

Liver Neoplasms

NCT03778957 2026-04-15

EMERALD-1

724 enrolled

Phase 2 Active not recruiting

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06679985 2026-04-13

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

72 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05301842 2026-04-07

EMERALD-3

760 enrolled

Phase 1/2 Active not recruiting

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04008797 2026-03-24

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

301 enrolled

GastrointestinalGynecologic

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06040099 2026-03-19

EMERALD-Y90

Phase 2 Active not recruiting

58 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03847428 2026-03-06

EMERALD-2

908 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05953337 2026-03-04

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

120 enrolled

Phase 1/2 Active not recruiting

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT05438420 2026-02-24

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

120 enrolled

GastrointestinalGynecologic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Stomach Neoplasms

NCT04736121 2026-02-03

DOORwaY90

100 enrolled

Phase 1 Active not recruiting

Liver Neoplasms

NCT07362264 2026-01-23

A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors

50 enrolled

Liver Neoplasms

NCT04573881 2026-01-12

#HOPE4LIVER

24 enrolled 12 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03383458 2025-11-21

CheckMate 9DX

545 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04572633 2025-11-19

#HOPE4LIVER US

47 enrolled 15 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05064553 2025-10-15

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

2,990 enrolled

Phase 1 Active not recruiting

Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Neoplasms

NCT03993873 2025-10-01

SHIELD-1

95 enrolled

GastrointestinalThoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT03132792 2025-08-15

AFPᶜ³³²T in Advanced HCC

Phase 1 Active not recruiting

45 enrolled

Liver Neoplasms, Neoplasm Metastasis

NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study